- Home
- ADMA vs SYNA Comparison
ADMA vs SYNA Comparison
Compare ADMA & SYNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADMA
- SYNA
- Stock Information
- Founded
- ADMA 2004
- SYNA 1986
- Country
- ADMA United States
- SYNA United States
- Employees
- ADMA N/A
- SYNA N/A
- Industry
- ADMA Biotechnology: Biological Products (No Diagnostic Substances)
- SYNA Computer peripheral equipment
- Sector
- ADMA Health Care
- SYNA Technology
- Exchange
- ADMA Nasdaq
- SYNA Nasdaq
- Market Cap
- ADMA 3.8B
- SYNA 3.5B
- IPO Year
- ADMA N/A
- SYNA 2002
- Fundamental
- Price
- ADMA $16.90
- SYNA $74.34
- Analyst Decision
- ADMA Strong Buy
- SYNA Strong Buy
- Analyst Count
- ADMA 4
- SYNA 10
- Target Price
- ADMA $21.25
- SYNA $99.00
- AVG Volume (30 Days)
- ADMA 2.5M
- SYNA 600.6K
- Earning Date
- ADMA 02-26-2025
- SYNA 02-06-2025
- Dividend Yield
- ADMA N/A
- SYNA N/A
- EPS Growth
- ADMA N/A
- SYNA N/A
- EPS
- ADMA 0.28
- SYNA 3.95
- Revenue
- ADMA $382,809,000.00
- SYNA $979,400,000.00
- Revenue This Year
- ADMA $66.90
- SYNA $10.90
- Revenue Next Year
- ADMA $13.76
- SYNA $13.25
- P/E Ratio
- ADMA $60.29
- SYNA $18.81
- Revenue Growth
- ADMA 63.39
- SYNA N/A
- 52 Week Low
- ADMA $5.02
- SYNA $67.83
- 52 Week High
- ADMA $23.64
- SYNA $115.85
- Technical
- Relative Strength Index (RSI)
- ADMA 48.60
- SYNA 39.80
- Support Level
- ADMA $15.70
- SYNA $79.00
- Resistance Level
- ADMA $16.60
- SYNA $89.81
- Average True Range (ATR)
- ADMA 0.69
- SYNA 4.36
- MACD
- ADMA 0.10
- SYNA -0.44
- Stochastic Oscillator
- ADMA 77.17
- SYNA 13.48
About ADMA ADMA Biologics Inc
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.
About SYNA Synaptics Incorporated $0.001 Par Value
Synaptics Inc is a producer of semiconductor solutions for the mobile, PC, and Internet of Things markets. The company develops human interface solutions that enable touch, display, fingerprint, video, audio, voice, AI, and connectivity functions for smartphones, PCs, Internet of Things products, and other electronic devices. Geographically, it derives a majority of revenue from China. The company operates in one segment: the development, marketing, and sale of semiconductor products used in electronic devices and products.